Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective therapeutic option for many malignant diseases. However, the efficacy of allo-HSCT is limited by the occurrence of destructive graft-versus-host disease (GVHD). Since allogeneic T cells are the driving force in the development of GVHD, their activation, proliferation, and differentiation are key factors to understanding GVHD pathogenesis. On the other hand, antigen-presenting cells (APCs) are essential for allogeneic T-cell priming and the development of GVHD. The T-box transcription factor T-bet is a master regulator for IFN-γ production and Th1 differentiation. T-bet also regulates the functions of APCs including dendritic cells (DCs) and B cells. Therefore, we investigated the role of T-bet in T cell responses, as well as on APC functions, in acute GVHD (aGVHD) using murine models of allogenic bone marrow transplantation (allo-BMT). In Chapter 2, we evaluated the roles of T-bet and IFN-γ in T-cell responses. T-bet-/- T cells induced significantly less GVHD compared with either wild-type (WT) or IFN-γ-/- counterparts in CD4-driven major histocompatibility complex (MHC)- or minor histocompatibility antigen (miHA)-mismatched models. We defined several T-bet-dependent but IFN-γ-independent molecules that may account for this distinct outcome. Further study indicates that T-bet also controls the optimal activity of Th17 cells to induce GVHD. Moreover, the compromised graft-versus-leukemia (GVL) effect of T-bet-/- T cells could be essentially reversed by IL-17 neutralization. Thus, targeting T-bet or regulating its downstream effectors independent of IFN-γ may be a promising strategy to control GVHD in the clinic. In Chapter 3, we evaluated the role of T-bet on APCs and found that T-bet-/- recipients developed much milder GVHD than their WT counterparts in MHC-mismatched or CD4-depedent miHA-mismatched models. As the functional readout of APCs, allogeneic donor T cells, particular CD4 subpopulation, significantly reduced IFN-γ production, proliferation and migration, and caused less damage in liver and gut in T-bet-/- recipients. We further observed that T-bet on recipient hematopoietic APCs, particular DCs, was primarily responsible for donor T-cell response and pathogenicity in GVHD. In fact, Trail/DR5 interaction served as a major signaling pathway responsible for donor T-cell apoptosis and impaired GVHD development in T-bet-/- recipients. Furthermore, T-bet expression on the host is largely dispensable for the GVL effect. Taken together, we propose that T-bet is a potential therapeutic target for the control of GVHD through regulating T cells as well as APCs. We believe further exploration and understanding of the immunobiology of T-bet in controlling the activities of T cells and APCs in GVHD will expand therapeutic options for the continuing success of allo-HSCT.

Fxrα est le récepteur nucléaire des acides biliaires, exprimé majoritairement dans le foie, l'intestin, les reins et les glandes surrénales. L'intérêt pour ce dernier est devenu croissant au cours des dernières années, de part le rôle central qu'il joue dans le contrôle de l'homéostasie du cholestérol, des acides biliaires, des triglycérides ou encore du glucose. Plus récemment, Fxrα ainsi que ses ligands, les acides biliaires, ont été localisés dans le testicule, soulevant la question du rôle potentiel de Fxrα dans cet organe, et plus généralement dans la fonction de reproduction mâle. Mais les études menées à ce sujet restent jusqu'à présent peu nombreuses, et focalisées sur son implication dans le contrôle du métabolisme des stéroïdes : l'activation in vivo de Fxrα par un agoniste synthétique conduit ainsi chez l'adulte à court terme à une répression de la stéroïdogenèse. Outre son rôle dans le contrôle de l'activité endocrine des cellules de Leydig, l'impact de l'activation in vivo de Fxrα sur la physiologie plus globale du testicule n'a jamais été abordé à ce jour. De telles études seraient pourtant pertinentes étant donné que Fxrα est ciblé pour le traitement de pathologies métaboliques telles que la dyslipidémie ou le diabète. Dans ce contexte, l'objectif de ce travail de thèse était d'étudier le rôle de Fxrα dans la physiologie et la pathophysiologie du testicule, en s'appuyant sur l'analyse d'un modèle murin dont le gène codant Fxrα a été invalidé. Nos résultats démontrent que : 1) la perte de Fxrα prédispose le testicule à une sur-mortalité des cellules germinales dans un contexte pathologique de cholestase ; 2) la sur-activation de la signalisation Fxrα au cours de la puberté conduit à un défaut de la différenciation germinale, associée à une altération de la fonction endocrine du testicule ; 3) outre la régulation de la stéroïdogenèse dans les cellules de Leydig, Fxrα participe au contrôle des fonctions sertoliennes et de la prolifération et / ou différenciation des cellules germinales souches. L'ensemble de ces données définissent Fxrα comme un nouvel acteur impliqué dans le contrôle de la physiologie testiculaire et devraient être prises en considération quant-à l'utilisation de molécules agonistes et / ou antagonistes de Fxrα dans le cadre du traitement de pathologies métaboliques. / Fxrα is the bile acid nuclear receptor, predominantly expressed in liver, intestine, kidney and adrenal glands. In recent years, interest in Fxrα has been increasing due to its central role in the control of cholesterol, bile acids, triglycerides or glucose homeostasis. More recently, Fxrα and its ligands, bile acids, have been detected in the testis pointing out its potential involvement in this tissue and more widely in the male reproductive functions. However, the few studies on this topic focused essentially on Fxrα involvement in the control of steroids metabolism. Indeed, activation of Fxrα in vivo with a synthetic agonist leads to short-term steroidogenesis repression in the adult. In vivo the impact of alteration of Fxrα signaling on the global testis physiology has never been explored so far. Such studies would be pertinent considering that Fxrα is a target for the treatment of metabolic diseases such as dyslipidemia or diabetes. In this context, the aim of my work was to study the implication of Fxrα in testis physiology and physiopathology by analyzing a knock out mouse model for Fxrα. Our results show that: 1) the loss of Fxrα increase germ cell mortality in the testis in a disease context of cholestasis ; 2) over-activation of Fxrα signaling during puberty leads to germ cell differentiation defects, associated with an alteration of testis endocrine function ; 3) besides steroidogenesis control in Leydig cell, Fxrα is involved in Sertoli cell functions and spermatogonial stem cell proliferation and/or differentiation. Taken together, these data define Fxrα as a new actor involved in the control of testis physiology, and should be taken into consideration regarding the use of Fxrα agonistic or antagonistic ligands for the treatment of metabolic diseases.

Submitted by Cláudia Bueno (claudiamoura18@gmail.com) on 2016-04-25T17:01:02Z No. of bitstreams: 2 Tese - Thaisa Campos Marques - 2016.pdf: 2492479 bytes, checksum: b5a2ef86d3f378ebc4e6976e2ca80765 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) / Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2016-04-26T10:50:25Z (GMT) No. of bitstreams: 2 Tese - Thaisa Campos Marques - 2016.pdf: 2492479 bytes, checksum: b5a2ef86d3f378ebc4e6976e2ca80765 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) / Made available in DSpace on 2016-04-26T10:50:25Z (GMT). No. of bitstreams: 2 Tese - Thaisa Campos Marques - 2016.pdf: 2492479 bytes, checksum: b5a2ef86d3f378ebc4e6976e2ca80765 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) Previous issue date: 2016-02-23 / Melatonin treatment and blastocoel collapse had been suggested to be potent options to enhance embryo development and viability after cryopreservation of bovine embryos. The present study tested these alternatives with the aim to improve cryotolerance of bovine embryos produced in vitro. First, the effects of melatonin (MEL) were evaluated at three concentrations in Maturation Media (IVM) and/or Culture Media (IVC) (0, 10-7, 10-9, 10-11 M). The results showed that MEL10-9 in IVM could improve slightly the cleavage rate. However, when applied during IVC, MEL10-9 resulted in improved blastocysts rates and reduced numbers of apoptotic cells (NAC), a higher expression of antioxidative genes without changing the expression metabolism-related, placentation and anti-apoptotic genes. After, the MEL treatment giving the best result in first experiment (MEL 10-9 M in IVC) was combined with blastocoel collapse (BC) immediatly before vitrification. The survival and embryo quality were investigated. This experiment confirmed that independent of BC, MEL supplementation in IVC enhanced re-expansion and hatching rates of vitrified embryos. However, embryos cultured without MEL required more time during re-culture for all expansion. Embryos produced with MEL had similar NAC irrespective of vitrification and BC. BC did not affect embryo quality, in terms of the expression of genes involved in metabolism, oxidative stress, cell repair, placentation and implantation. Therefore, this research concluded that: (i) at 10-9 M concentration, MEL used during IVC improved embryo quality and development, and it minimized the oxidative stress and apoptosis in cells; (ii) embryos cultured with melatonin, vitrified and re-cultured can be transfered in less time; (iii) the blastocoel collapse benefited hatching when embryos were cultured with MEL in IVC; (iv) embryos cultured in IVC with MEL showed better quality and viability, and independently of BC. This information has a potential value for researchs on embryo cryotolerance. / O tratamento com melatonina e a retirada do fluido da blastocele de blastocistos tem sido sugeridos como potentes opções para melhorar o desenvolvimento e a viabilidade embrionária após a criopreservação de embriões de bovinos. O presente estudo testou essas alternativas com o objetivo de melhorar a criotolerância de embriões bovinos produzidos in vitro. Em primeiro lugar, os efeitos da melatonina (MEL) foram avaliados em três concentrações no meio de maturação (MIV) e/ou meio de cultivo (CIV) (0, 10-7, 10-9, 10-11 M). Os resultados mostraram que MEL10-9 no MIV pode melhorar significativamente a taxa de clivagem. No entanto, quando aplicado durante o CIV, MEL10-9 resultou em melhores taxas de blastocistos, reduzido número de células apoptóticas (NCA), maior expressão de genes antioxidantes sem alterar a expressão de genes anti-apoptóticos e relacionados ao metabolismo e placentação. Depois, o tratamento de MEL com melhor resultado no primeiro experimento (MEL 10-9 M no CIV) foi combinado com a retirada do fluido da blastocele (RFB) imediatamente antes da vitrificação. Foram investigadas a qualidade e sobrevivência de embriões. Este estudo confirmou que independente da RFB, a suplementação MEL no CIV melhorou a re-expansão e eclosão dos embriões vitrificados. No entanto, embriões cultivados sem MEL necessitou de maior período de recultivo para sua total re-expansão. Embriões produzidos com MEL tiveram similar NCA, independentemente da vitrificação e RFB. A RFB não afetou a qualidade do embrião em termos de expressão de genes envolvidos no metabolismo, estresse oxidativo, reparo celular, placentação e implantação. Portanto, esta investigação conclui que: (i) na concentração de 10-9 M, MEL utilizada no CIV melhorou a qualidade e desenvolvimento do embrião e, minimizou o estresse oxidativo e a apoptose celular; (ii) os embriões cultivados com MEL, vitrificados e re-cultivados podem ser transferidos em menor tempo; (iii) a RFB beneficiou a eclosão quando os embriões foram cultivados com MEL no CIV; (iv) embriões produzidos com MEL no CIV apresentaram melhor qualidade e viabilidade, independentemente da RFB. Esta informação tem um valor potencial para pesquisas sobre criotolerância embrionária.

In this project I sought to analyse the effects of different free fatty acids (FFAs) on INS-1E β-cells. The saturated fatty acid palmitate is considered toxic whereas the monounsaturated fatty acid oleate is harmless. In my working hypothesis I assumed an additional protective effect of oleate when used in combination with palmitate. Furthermore I aimed to explore in detail the possible causes and signalling pathways responsible for apoptosis or sustained cell survival. I examined the Endoplasmic Reticulum (ER) stress response, called unfolded protein response (UPR), as one essential criterion deciding about cell death or life. Analysis of viability and apoptosis confirmed the deleterious effect of palmitate on INS-1E β-cells after 24h of incubation. Oleate proved not to be harmful and even reversed the toxicity of palmitate. When the main components of the UPR were assessed using Western blot analyses and quantitative PCR was performed I found positive proof that palmitate activated the UPR and ultimately led to apoptosis. By contrast, oleate completely prevented UPR signalling. I conclude that oleate rescues INS-1E β-cells by inhibiting ER stress and its signalling.

A major challenge in designing cancer therapies is the induction of cancer cell apoptosis, although activation of intrinsic apoptotic pathways by targeting gold nanoparticles to mitochondria is promising. We report an in vitro procedure targeting mitochondria with conjugated gold nanoparticles and investigating effects on apoptosis induction in the human breast cancer cell line Jimt-1. Gold nanoparticles were conjugated to a variant of turbo green fluorescent protein (mitoTGFP) harbouring an amino-terminal mitochondrial localization signal. Au nanoparticle conjugates were further complexed with cationic maltotriose-modified poly(propylene imine) third generation dendrimers. Fluorescence and transmission electron microscopy revealed that Au nanoparticle conjugates were directed to mitochondria upon transfection, causing partial rupture of the outer mitochondrial membrane, triggering cell death. The ability to target Au nanoparticles into mitochondria of breast cancer cells and induce apoptosis reveals an alternative application of Au nanoparticles in photothermal therapy of cancer.